Big retailers are still attempting to shape new clinical lines of business, betting that some of them will eventually become profitable. Attention has now turned to GLP-1s. Yet against this backdrop, healthcare’s market reality is still leading to scaled-back expansion plans, noticeable exits, and massive financial write-downs for some retailers. The market is rather hit-or-miss right now. For example, Amazon continues to open primary care clinics through health system partnerships (including about 200 sites, according …
Read More